These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8105477)

  • 1. Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis.
    Mock BA; Krall MM; Dosik JK
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9499-503. PubMed ID: 8105477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility.
    Zhang SL; DuBois W; Ramsay ES; Bliskovski V; Morse HC; Taddesse-Heath L; Vass WC; DePinho RA; Mock BA
    Mol Cell Biol; 2001 Jan; 21(1):310-8. PubMed ID: 11113205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice.
    Potter M; Morrison S; Wiener F; Zhang XK; Miller FW
    J Natl Cancer Inst; 1994 Jul; 86(14):1058-65. PubMed ID: 8021954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoupling of DNA excision repair and RNA transcription in translocation breaksite regions of plasmacytoma-susceptible BALB/cAnPt mice.
    Beecham EJ; Owens JD; Shaughnessy JD; Huppi K; Bohr VA; Mushinski JF
    Carcinogenesis; 1997 Apr; 18(4):687-94. PubMed ID: 9111201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The plasmacytoma resistance gene, Pctr2, delays the onset of tumorigenesis and resides in the telomeric region of chromosome 4.
    Mock BA; Hartley J; Le Tissier P; Wax JS; Potter M
    Blood; 1997 Nov; 90(10):4092-8. PubMed ID: 9354679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pristane induces an indomethacin inhibitable inflammatory influx of CD4+ T cells and IFN-gamma production in plasmacytoma-susceptible BALB/cAnPt mice.
    McDonald AH; Degrassi A
    Cell Immunol; 1993 Jan; 146(1):157-70. PubMed ID: 8425224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.
    Zhang S; Ramsay ES; Mock BA
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2429-34. PubMed ID: 9482902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice.
    Potter M; Mushinski EB; Wax JS; Hartley J; Mock BA
    Cancer Res; 1994 Feb; 54(4):969-75. PubMed ID: 8313388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of MuLV-related genes on plasmacytomagenesis in BALB/c mice.
    Potter M; Hartley JW; Wax JS; Gallahan D
    J Exp Med; 1984 Aug; 160(2):435-40. PubMed ID: 6088663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA repair defects associated with chromosomal translocation breaksite regions.
    Beecham EJ; Jones GM; Link C; Huppi K; Potter M; Mushinski JF; Bohr VA
    Mol Cell Biol; 1994 Feb; 14(2):1204-12. PubMed ID: 8289801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility and resistance to J3V1 retrovirus-induced murine plasmacytomagenesis in reconstituted severe combined immunodeficient mice.
    Hilbert DM; Pumphrey JG; Troppmair J; Rapp UR; Rudikoff S
    Oncogene; 1993 Jul; 8(7):1993-2000. PubMed ID: 7685514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations.
    Potter M; Wiener F
    Carcinogenesis; 1992 Oct; 13(10):1681-97. PubMed ID: 1423827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BALB/c.CBA/N mice carrying the defective Btk(xid) gene are resistant to pristane-induced plasmacytomagenesis.
    Potter M; Wax JS; Hansen CT; Kenny JJ
    Int Immunol; 1999 Jul; 11(7):1059-64. PubMed ID: 10383938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High resolution banding analysis of the involvement of strain BALB/c- and AKR-derived chromosomes No. 15 in plasmacytoma-specific translocations.
    Wiener F; Babonits M; Bregula U; Klein G; Léonard A; Wax JS; Potter M
    J Exp Med; 1984 Jan; 159(1):276-91. PubMed ID: 6607313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonrandom chromosomal change (trisomy 11) in murine plasmacytomas induced by an ABL-MYC retrovirus.
    Wiener F; Coleman A; Mock BA; Potter M
    Cancer Res; 1995 Mar; 55(5):1181-8. PubMed ID: 7867005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene.
    Bliskovsky V; Ramsay ES; Scott J; DuBois W; Shi W; Zhang S; Qian X; Lowy DR; Mock BA
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14982-7. PubMed ID: 14634209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential susceptibility of BALB/c and DBA/2 cells to plasmacytoma induction in reciprocal chimeras.
    Silva S; Sugiyama H; Babonits M; Wiener F; Klein G
    Int J Cancer; 1991 Sep; 49(2):224-8. PubMed ID: 1879968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of immunoglobulin/c-myc recombinations in mice that are resistant to plasmacytoma induction.
    Müller JR; Jones GM; Potter M; Janz S
    Cancer Res; 1996 Jan; 56(2):419-23. PubMed ID: 8542601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two major interacting chromosome loci control disease susceptibility in murine model of spondyloarthropathy.
    Végvári A; Szabó Z; Szántó S; Nesterovitch AB; Mikecz K; Glant TT; Adarichev VA
    J Immunol; 2005 Aug; 175(4):2475-83. PubMed ID: 16081819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multigenic control of skin tumor susceptibility in SENCARA/Pt mice.
    Mock BA; Lowry DT; Rehman I; Padlan C; Yuspa SH; Hennings H
    Carcinogenesis; 1998 Jun; 19(6):1109-15. PubMed ID: 9667751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.